Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1980-01-09
1985-11-26
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514397, 514399, 546210, 548252, 548335, 548336, A61K 31415, C07D23360
Patent
active
045555168
ABSTRACT:
The N-(substituted benzyl) imidazoles are selective enzyme inhibitors and thus are useful in the treatment of heart disease, circulatory and vascular problems.
REFERENCES:
patent: 4118487 (1978-10-01), Regel et al.
patent: 4183742 (1980-01-01), Sasse et al.
Johnson, A., et al., J. Med. Chem., 12, 1024 (1969).
Baggaley, K., et al., J. Med. Chem., 18, 833 (1975).
Moncada S., et al., Prostaglandins, vol. 13, pp. 611-618 (1977).
Needleman, P., et al., Proc. Nat'l. Acad. Sci., USA, vol. 74, pp. 1716-1720 (1977).
Tai, H., et al., Biochem. Biophys. Res. Commun., vol. 80, pp. 236-242 (1978).
Yoshimoto, T., et al., Prostaglandins, vol. 16, pp. 529-540 (1978).
Cross Peter E.
Dickinson Roger P.
Blackwood Robert K.
Frost Albert E.
Knuth Charles J.
Pfizer Inc.
Schwartz Richard A.
LandOfFree
N-Benzyl-imidazoles as selective inhibitors of the thromboxane s does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-Benzyl-imidazoles as selective inhibitors of the thromboxane s, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-Benzyl-imidazoles as selective inhibitors of the thromboxane s will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-270035